scholarly journals Cervicomastoidfacial versus modified facelift incision for parotid surgery: a patient feedback comparison

2010 ◽  
Vol 92 (1) ◽  
pp. 40-43 ◽  
Author(s):  
Joseph Wasson ◽  
Haider Karim ◽  
Justin Yeo ◽  
Jaan Panesar

INTRODUCTION Traditionally, the cervicomastoidfacial (CMF) incision is used to excise benign tumours of the parotid gland. The rhytidectomy or modified facelift (MF) incision allows an alternative approach which leaves no visible neck scar. The objective of this study was to establish the frequency of each surgical approach used and identify any difference in complication and patient satisfaction between the two incisions for benign conditions of the parotid gland. PATIENTS AND METHODS A retrospective analysis of 101 case notes for patients who underwent parotidectomy by both ENT and maxillofacial departments between January 2006 and February 2008 was undertaken. All histologically confirmed cases of malignancy were excluded. For each incision, immediate postoperative complications were obtained from the notes. A postal patient outcome evaluation questionnaire sought information regarding persistent and late complications as well as a visual analogue scar satisfaction score for both incisions. RESULTS Overall, 79 parotidectomies were included (59 CMF incisions, 20 MF incisions). Of CMF incisions, 34% suffered facial weakness immediately postoperatively versus 20% of MF incisions. Of CMF incisions, 4% suffered postoperative haematomas versus none following MF incisions. In the study cohort, 47 (60%) responded to the postal feedback questionnaire (33 CMF versus 14 MF respondents). Information regarding immediate and late postoperative ipsilateral facial paraesthe-sia and gustatory sweating was obtained. Mean visual analogue scar satisfaction scores were 9.4 for CMF incisions and 8.9 for MF incisions. CONCLUSIONS Immediate and late complications for CMF and MF approaches for benign disease parotidectomy were comparable, but scar satisfaction following MF incision was not greater than CMF incisions.

2009 ◽  
Vol 76 (2) ◽  
pp. 202-206 ◽  
Author(s):  
Marcel E. Reinders ◽  
Annette H. Blankenstein ◽  
Dirk L. Knol ◽  
Henrica C.W. de Vet ◽  
Harm W.J. van Marwijk

1975 ◽  
Vol 89 (4) ◽  
pp. 435-444 ◽  
Author(s):  
N. A. Shaheen ◽  
G. T. Harboyan ◽  
R. I. Nassif

SummaryCYSTS of the major salivary glands are most frequent in the parotid where they form a small percentage of its benign tumours. They can be congenital or acquired and of parotid or extraparotid origin. Two unusual cysts are reported: a cholesteatoma arising from the ipsilateral mastoid, twenty years after successful radical mastoidectomy, and a deeply located cyst of probable congenital origin. The literature is reviewed and the management discussed. Parotidectomy, often with extensive dissection, remains in general the treatment of choice.Cysts in the parotid gland represent a small percentage of benign parotid masses. They usually arise within the gland from salivary or non-salivary parotid tissue, and may be congenital or acquired. Some, however, may arise from surrounding structures.Unless the cyst is superficial and therefore readily amenable to proper examination, it usually escapes a definite diagnosis even with the help of sialography or more sophisticated procedures. Exploration is eventually resorted to for diagnosis and treatment. That is why the surgeon should be ready to perform extensive surgery if the findings at exploration necessitate it.The purpose of this article is to present two cystic lesions of the parotid. The first is a rarity, a cholesteatoma originating from the ipsilateral mastoid; and the second an unusually deeply located cyst. These cases illustrate well the problems met with in the management of preauricular masses.


2019 ◽  
Vol 49 (12) ◽  
pp. 1120-1125 ◽  
Author(s):  
Yin Mi ◽  
Pengwei Lv ◽  
Fang Wang ◽  
Lin Li ◽  
Mingzhi Zhu ◽  
...  

Abstract Objective The purpose of this study was to evaluate the efficacy, late complications, and cosmetic outcomes of targeted intraoperative radiotherapy for the treatment of Chinese patients with early-stage breast cancer. Methods Between September 2014 and May 2017, breast cancer patients undergoing targeted intraoperative radiotherapy at our facility were retrospectively recruited for this study. Intraoperative radiotherapy was performed with a 50-kV X-ray source in an Intrabeam system (Carl Zeiss Meditec, Oberkochen, Germany). The one-time prescribed irradiation dose to the tumour bed was 20 Gy. Recurrence, death, late complications, and cosmetic outcomes were recorded. Late radiotoxicity was assessed based on the grading criteria of the Radiation Therapy Oncology Group. Results A total of 77 patients who were treated with targeted intraoperative radiotherapy only were recruited. The cohort had a mean age of 58 years; patients with T1, N0, and invasive ductal carcinoma accounted for 75.3, 89.6, and 84.4%, respectively; the median follow-up duration was 40 months; there were 2 patients of recurrence and 2 patients of death. There were no patients of cardiac toxicity or skin or lung radiotoxicity of grade 2 or above. The main complications were breast oedema (18.2%), seroma (15.6%), chromatosis (9.1%), induration (7.8%), pain (5.2%), skin depression (2.6%), mild dry cough (2.6%), delayed wound healing (1.3%), and wound infection (1.3%). Seventy-three patients participated in the cosmetic outcome evaluation, which yielded an excellent or good rate of 95.9%. Conclusions Due to its low recurrence rates, lack of high-grade late radiotoxicity, and excellent cosmetic outcomes, targeted intraoperative radiotherapy may be a suitable treatment for select early-stage breast cancer patients in China.


1990 ◽  
Vol 104 (9) ◽  
pp. 706-708 ◽  
Author(s):  
R. Comoretto ◽  
L. Barzan

AbstractThe method of surgical treatment for benign tumours of the parotid gland has not yet been rationalized, but many authors recommend parotidectomy as the most appropriate procedure. A series of 289 operations for parotid swellings is reported; the majority of mixed and Warthin's tumours underwent enucleation without either complications or recurrence. The rationale of parotidectomy versus enucleation is discussed but in fast growing, deeply infiltrating and recurrent tumours, parotidectomy appears to be the best choice. In the other group of more commonly occurring tumours, enucleation represents a reliable time saving option.


Author(s):  
Dheer S. Kalwaniya ◽  
Goutam Kothathi Chowdegowda ◽  
Monish Raj ◽  
Jaspreet S. Bajwa ◽  
Satya V. Arya ◽  
...  

<p class="abstract"><strong>Background:</strong> The pleomorphic adenoma comprises 45-60% of all salivary gland tumors most often in parotid gland up to 80%. The association between the facial nerve and the gland is responsible for most of the technical difficulties and complications of the surgical approaches.</p><p class="abstract"><strong>Methods:</strong> This is a retrospective observational study performed in a unit of General Surgery, Safdarjung Hospital, New Delhi from May 2011 to October 2019 of all patients who underwent superficial parotidectomy for pleomorphic adenoma of parotid gland. The data was tabulated and results made using SPSS 21.0 system.  </p><p class="abstract"><strong>Results:</strong> Male:female ratios are 29:33. Average age was 47.1 years (31-61). Average duration of disease was 2.2 years (0.3-5). 4 were operated for recurrence. Facial paresis occurred in 7 out of 62 patients (11.3%), 4 females and 3 males. 11 patients have tumor greater than 4 cm, out of these 11 patients 2 patients had pre-op facial paresis. Out of 51 patients (size &lt;4 cm), 2 suffered facial paresis and out of 11 patients (size &gt;4 cm), 5 suffered same. Out of 59 patients with depth of tumor &lt;2 cm, 4 patients had post-op facial paresis. All the three patients having tumor depth &gt;2 cm suffered post op facial paresis. Patients with pre-op facial nerve paresis had mean duration of tumor 3.35 year (±0.92) while with post-op facial nerve paresis had mean duration of tumor 2.99 year (±1.35).</p><p class="abstract"><strong>Conclusions:</strong> Meticulous separation of facial nerve from parotid tissue is key to preservation of the facial nerve. But factors like size of tumor, depth of invasion, previous surgery do affect the outcome in parotid surgery.</p>


2020 ◽  
Vol 27 (04) ◽  
pp. 870-872
Author(s):  
Afra Samad ◽  
Namra Mahmood ◽  
Arbaz Samad

We are reporting a case of tuberculosis within warthin tumour of left parotid area in a 72 years old male with findings of benign tumour with acute and chronic inflammation on FNA (Fine Needle Aspiration). Warthin tumour is a benign tumours of the salivary gland particularly parotid region. It is the second most common benign tumour. In addition the tuberculosis in a parotid gland is very rare. Further having tuberculosis within warthin tumour is quite rare.1 To best of our knowledge there is the only few cases which are being reported.


1994 ◽  
Vol 108 (7) ◽  
pp. 574-578 ◽  
Author(s):  
David J. Terris ◽  
Katherine M. Tuffo ◽  
Willard E. Fee

AbstractThe most commonly used incision for parotidectomies is the modified Blair incision. We have successfully used an alternative incision which allows good exposure, and leaves no neck scar.Between 1 March 1989 and 1 August 1991, 18 parotidectomies were performed using a modified facelift incision. Fifteen parotidectomies were done for similar indications during the same period using a modified Blair incision. The mean age in both groups of patients was 40.3 years. The pathology and incidence of complications was similar in the two groups. The difference in mean (±SD) time of surgery between the two groups was not statistically significant: 3.14 ±0.75 hours in patients with a modified facelift incision and 3.25 ±1.27 hours in patients with a modified Blair incision (p<20.1).The modified facelift incision is an alternative approach to parotidectomy for selected patients. It provides adequate exposure, even for a total parotidectomy and mastoidectomy and it results in improved patient satisfaction without additional risk of complications.


2017 ◽  
Vol 5 ◽  
pp. 2050313X1774908
Author(s):  
Krzysztof Piersiala ◽  
Hanna Klimza ◽  
Joanna Jackowska ◽  
Małgorzata Wierzbicka

Cholesteatoma is a pathological tissue that may extend into all parts of temporal bone and rarely, as this study highlights, beyond its structures. Nevertheless, the spread outside the mastoid tip into the soft tissues of the neck or parotid space is very rare. The case of 23-year-old male with right parotid mass is presented. The patient had history (2006, 2009, and 2012) of three tympanoplastics for recurrent right ear cholesteatoma. The parotid tumor was revealed incidentally in magnetic resonance imaging in January 2016, but the imaging was inconclusive. After 6 months, the patient developed right-sided facial nerve palsy. The second look of the right ear was performed with simultaneous parotid surgery. The ear was healed and free of cholesteatoma, but the parotid mass resembled the cholesteatoma confirmed later on by histological examination. The tumor extended from stylomastoid foramen. This case was unusual as the disease had extended beyond the ear with the bony parts of the mastoid being preserved. To our knowledge, this is the first case report to describe a parotid gland cholesteatoma not being an extension of a cholesteatoma present in the tympanic cavity and entering the parotid gland via stylomastoid foramen.


Sign in / Sign up

Export Citation Format

Share Document